A detailed history of Daiwa Securities Group Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 107,114 shares of LLY stock, worth $97 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
107,114
Previous 93,420 14.66%
Holding current value
$97 Million
Previous $54.5 Million 53.02%
% of portfolio
0.47%
Previous 0.34%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $8.11 Million - $10.8 Million
13,694 Added 14.66%
107,114 $83.3 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $2.56 Million - $3.01 Million
4,865 Added 5.49%
93,420 $54.5 Million
Q3 2023

Nov 01, 2023

BUY
$434.7 - $599.3 $769,853 - $1.06 Million
1,771 Added 2.04%
88,555 $47.6 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $511,378 - $683,772
1,458 Added 1.71%
86,784 $40.7 Million
Q1 2023

May 02, 2023

BUY
$310.63 - $364.82 $4.11 Million - $4.83 Million
13,239 Added 18.37%
85,326 $29.3 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $884,584 - $1.03 Million
2,751 Added 3.97%
72,087 $26.4 Million
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $75,898 - $86,494
256 Added 0.37%
69,336 $22.4 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $493,352 - $579,267
1,770 Added 2.63%
69,080 $22.4 Million
Q1 2022

Apr 29, 2022

SELL
$234.69 - $291.66 $537,440 - $667,901
-2,290 Reduced 3.29%
67,310 $19.3 Million
Q4 2021

Feb 03, 2022

BUY
$224.85 - $279.04 $1.65 Million - $2.05 Million
7,335 Added 11.78%
69,600 $19.2 Million
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $360,321 - $443,426
-1,626 Reduced 2.54%
62,265 $14.4 Million
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $919,902 - $1.19 Million
-5,095 Reduced 7.39%
63,891 $14.7 Million
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $3.87 Million - $5.01 Million
-23,567 Reduced 25.46%
68,986 $12.9 Million
Q4 2020

Feb 04, 2021

BUY
$130.46 - $172.63 $5.56 Million - $7.35 Million
42,582 Added 85.21%
92,553 $15.6 Million
Q3 2020

Nov 02, 2020

BUY
$146.22 - $169.13 $288,784 - $334,031
1,975 Added 4.11%
49,971 $7.4 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $1.12 Million - $1.39 Million
9,411 Added 24.39%
47,996 $6.66 Million
Q4 2019

Jan 31, 2020

BUY
$106.92 - $132.43 $248,268 - $307,502
2,322 Added 6.4%
38,585 $5.07 Million
Q3 2019

Nov 04, 2019

BUY
$106.79 - $116.16 $111,381 - $121,154
1,043 Added 2.96%
36,263 $4.06 Million
Q2 2019

Jul 24, 2019

SELL
$110.79 - $129.32 $700,303 - $817,431
-6,321 Reduced 15.22%
35,220 $3.9 Million
Q1 2019

Apr 26, 2019

SELL
$111.31 - $131.02 $805,884 - $948,584
-7,240 Reduced 14.84%
41,541 $5.39 Million
Q4 2018

Feb 05, 2019

BUY
$105.9 - $118.64 $141,482 - $158,503
1,336 Added 2.82%
48,781 $5.65 Million
Q3 2018

Nov 01, 2018

BUY
$85.86 - $107.31 $652,536 - $815,556
7,600 Added 19.07%
47,445 $5.09 Million
Q2 2018

Jul 30, 2018

SELL
$75.7 - $86.88 $497,500 - $570,975
-6,572 Reduced 14.16%
39,845 $3.4 Million
Q1 2018

May 02, 2018

BUY
$74.21 - $87.6 $179,513 - $211,904
2,419 Added 5.5%
46,417 $3.59 Million
Q4 2017

Feb 06, 2018

BUY
$81.94 - $87.89 $98,737 - $105,907
1,205 Added 2.82%
43,998 $3.72 Million
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $3.3 Million - $3.66 Million
42,793
42,793 $3.66 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.